Headache

ABSTRACT

Headache is one of the most common complaints among patients presenting to an outpatient neurology practice. The evaluation, diagnosis, and treatment of headache can be rather cumbersome and at times quite challenging for even the most seasoned neurologist. Many complex issues that although not causative, can play an exacerbating role in the genesis of headaches. In this article, the authors review some of the essential elements that are part of headache evaluation including headache-specific history, physical examination, warning signs of secondary headache disorders, and when to consider further studies. They then provide a brief review on the diagnosis of primary headache disorders according to the International Headache Society's International Classification of Headache Disorders, 2nd Edition (ICHD-2), and treatment strategies of the more common primary headache disorders with a focus on migraine, trigeminal autonomic cephalalgias, tension-type headache, and chronic daily headache.

KEYWORDS

Primary headache - migraine - trigeminal autonomic cephalgias - cluster headache - tension-type headache

REFERENCES

• 1 Headache Classification Subcommittee of the International Headache Society . The International Classification of Headache Disorders: 2nd edition.  Cephalalgia. 2004;  24 (Suppl 1) 9-160
• 2 Lipton R B, Stewart W F, Simon D. Medical consultation for migraine: results from the American Migraine Study.  Headache. 1998;  38 (2) 87-96
• 3 Lipton R B, Stewart W F, Diamond S, Diamond M L, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II.  Headache. 2001;  41 (7) 646-657
• 4 Lipton R B, Diamond S, Reed M, Diamond M L, Stewart W F. Migraine diagnosis and treatment: results from the American Migraine Study II.  Headache. 2001;  41 (7) 638-645
• 5 Olesen J, Bousser M G, Diener H C Headache Classification Committee et al. New appendix criteria open for a broader concept of chronic migraine.  Cephalalgia. 2006;  26 (6) 742-746
• 6 Ferrari M D, Goadsby P J, Roon K I, Lipton R B. Triptans (serotonin, 5–HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.  Cephalalgia. 2002;  22 (8) 633-658
• 7 Wenzel R G, Tepper S, Korab W E, Freitag F. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?.  Ann Pharmacother. 2008;  42 (11) 1692-1696
• 8 Pascual J, Leira R, Láinez J M. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients.  Cephalalgia. 2003;  23 (10) 961-962
• 9 Blumenfeld A M, Schim J D, Chippendale T J. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.  Headache. 2008;  48 (2) 210-220
• 10 Mathew N T, Jaffri S F. A double-blind comparison of onabotulinumtoxinA (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.  Headache. 2009;  49 (10) 1466-1478
• 11 Rollnik J D, Wohlfarth K, Dengler R, Bigalke H. Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.  Neurol Clin Neurophysiol. 2001;  2001 (3) 2-4
• 12 Herrmann J, Geth K, Mall V et al.. Clinical impact of antibody formation to botulinum toxin A in children.  Ann Neurol. 2004;  55 (5) 732-735
• 13 Shuhendler A J, Lee S, Siu M et al.. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.  Pharmacotherapy. 2009;  29 (7) 784-791
• 14 Aurora S K, Dodick D W, Turkel C C PREEMPT 1 Chronic Migraine Study Group et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.  Cephalalgia. 2010;  30 (7) 793-803
• 15 Dodick D W, Turkel C C, DeGryse R E PREEMPT Chronic Migraine Study Group et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.  Headache. 2010;  50 (6) 921-936
• 16 Newman L, Mannix L K, Landy S et al.. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.  Headache. 2001;  41 (3) 248-256
• 17 MacGregor E A, Brandes J L, Silberstein S et al.. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.  Headache. 2009;  49 (9) 1298-1314
• 18 Rothrock J F. Menstrual migraine.  Headache. 2009;  49 (9) 1399-1400
• 19 Garza I, Swanson J W. Prophylaxis of migraine.  Neuropsychiatr Dis Treat. 2006;  2 (3) 281-291
• 20 Goadsby P J, Cittadini E, Burns B, Cohen A S. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments.  Curr Opin Neurol. 2008;  21 (3) 323-330
• 21 Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: a meta-analysis of population-based studies.  Cephalalgia. 2008;  28 (6) 614-618
• 22 Ladda J, Straube A, Förderreuther S, Krause P, Eggert T. Quantitative sensory testing in cluster headache: increased sensory thresholds.  Cephalalgia. 2006;  26 (9) 1043-1050
• 23 Bahra A, Gawel M J, Hardebo J E, Millson D, Breen S A, Goadsby P J. Oral zolmitriptan is effective in the acute treatment of cluster headache.  Neurology. 2000;  54 (9) 1832-1839
• 24 Hedlund C, Rapoport A M, Dodick D W, Goadsby P J. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.  Headache. 2009;  49 (9) 1315-1323
• 25 Hardebo J E, Dahlöf C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache.  Cephalalgia. 1998;  18 (7) 487-489
• 26 Ekbom K. The Sumatriptan Cluster Headache Study Group . Treatment of acute cluster headache with sumatriptan.  N Engl J Med. 1991;  325 (5) 322-326
• 27 Cohen A S, Burns B, Goadsby P J. High-flow oxygen for treatment of cluster headache: a randomized trial.  JAMA. 2009;  302 (22) 2451-2457
• 28 Mathew N T. Dosing and administration of ergotamine tartrate and dihydroergotamine.  Headache. 1997;  37 (Suppl 1) S26-S32
• 29 Matharu M S, Goadsby P J. Trigeminal autonomic cephalalgias: diagnosis and management. In: Silberstein S D, Lipton R B, Dodick D W, eds. Wolff's Headache and Other Head Pain. 8th ed. New York: Oxford University Press; 2008: 379-402
• 30 Tobin J, Flitman S. Occipital nerve blocks: when and what to inject?.  Headache. 2009;  49 (10) 1521-1533
• 31 Cohen A S, Matharu M S, Goadsby P J. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy.  Neurology. 2007;  69 (7) 668-675
• 32 Sostak P, Krause P, Förderreuther S, Reinisch V, Straube A. Botulinum toxin type-A therapy in cluster headache: an open study.  J Headache Pain. 2007;  8 (4) 236-241
• 33 Ailani J, Young W B. The role of nerve blocks and botulinum toxin injections in the management of cluster headaches.  Curr Pain Headache Rep. 2009;  13 (2) 164-167
• 34 Jarrar R G, Black D F, Dodick D W, Davis D H. Outcome of trigeminal nerve section in the treatment of chronic cluster headache.  Neurology. 2003;  60 (8) 1360-1362
• 35 Ford R G, Ford K T, Swaid S, Young P, Jennelle R. Gamma knife treatment of refractory cluster headache.  Headache. 1998;  38 (1) 3-9
• 36 Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience.  Neurology. 2006;  67 (1) 150-152
• 37 Burns B, Watkins L, Goadsby P J. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients.  Neurology. 2009;  72 (4) 341-345
• 38 Schwedt T J, Dodick D W, Trentman T L, Zimmerman R S. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features.  Cephalalgia. 2006;  26 (8) 1025-1027
• 39 Rasmussen B K. Epidemiology of headache.  Cephalalgia. 1995;  15 (1) 45-68
• 40 Mathew P, Peterlin B. Tension-type headache. In: Jay G W, ed. Clinician's Guide to Chronic Headache and Facial Pain. New York: Informa Healthcare; 2010: 16-26
• 41 Lyngberg A C, Rasmussen B K, Jørgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study.  Neurology. 2005;  65 (4) 580-585
• 42 Jensen R, Olesen J. Initiating mechanisms of experimentally induced tension-type headache.  Cephalalgia. 1996;  16 (3) 175-182 discussion 138-139
• 43 Sandrini G, Antonaci F, Pucci E, Bono G, Nappi G. Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine.  Cephalalgia. 1994;  14 (6) 451-457 discussion 394-395
• 44 Jensen R, Fuglsang-Frederiksen A. Quantitative surface EMG of pericranial muscles. Relation to age and sex in a general population.  Electroencephalogr Clin Neurophysiol. 1994;  93 (3) 175-183
• 45 Dahlöf C GH, Jacobs L D. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache.  Cephalalgia. 1996;  16 (2) 117-123
• 46 Steiner T J, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol.  Cephalalgia. 2003;  23 (1) 59-66
• 47 Prior M J, Cooper K M, May L G, Bowen D L. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial.  Cephalalgia. 2002;  22 (9) 740-748
• 48 Kubitzek F, Ziegler G, Gold M S, Liu J M, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache.  Eur J Pain. 2003;  7 (2) 155-162
• 49 Brennum J, Brinck T, Schriver L et al.. Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache.  Eur J Neurol. 1996;  3 23-28
• 50 Cady R K, Gutterman D, Saiers J A, Beach M E. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.  Cephalalgia. 1997;  17 (5) 588-590
• 51 Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache.  Cephalalgia. 2000;  20 (6) 603-610
• 52 Goadsby T, Silberstein S, Dodick D. Chronic Daily Headache for Clinicians. Hamilton: BC Decker Inc; 2005: 57-64
• 53 Saper J R, Lake III A E, Cantrell D T, Winner P K, White J R. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.  Headache. 2002;  42 (6) 470-482
• 54 Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.  Headache. 1992;  32 (10) 509-513
• 55 Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache.  Neurology. 2004;  62 (10) 1706-1711
• 56 Holroyd K A, Labus J S, O'Donnell F J, Cordingley G E. Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.  Headache. 2003;  43 (9) 999-1004
• 57 Padberg M, de Bruijn S F, de Haan R J, Tavy D L. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.  Cephalalgia. 2004;  24 (8) 675-680
• 58 Rozen D, Sharma J. Treatment of tension-type headache with botox: a review of the literature.  Mt Sinai J Med. 2006;  73 (1) 493-498
• 59 Harden R N, Cottrill J, Gagnon C M et al.. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.  Headache. 2009;  49 (5) 732-743
• 60 Garza I, Schwedt T J. Diagnosis and management of chronic daily headache.  Semin Neurol. 2010;  30 (2) 154-166
• 61 Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z et al.. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.  Cephalalgia. 2007;  27 (11) 1219-1225
• 62 Bigal M E, Lipton R B. Excessive acute migraine medication use and migraine progression.  Neurology. 2008;  71 (22) 1821-1828